Research has demonstrated that ERβ mediates the proliferative effects of E2 in lung cancer cells, influencing the regulation of the cell cycle and promoting the formation of tumors via pathways such as PI3K/Akt and MAPK/ERK [69,70,71]. Here, AKT1 is linked to lung cancer.